International Clinical Trial: Evaluation of Safety and Efficacy of Intranasal Administration of iPS Cell-derived Exosomes in Mild Cognitive Impairment

Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (JPRN-jRCT1033250410) titled 'Evaluation of Safety and Efficacy of Intranasal Administration of iPS Cell-derived Exosomes in Mild Cognitive Impairment' on Oct. 3.

Study Type: Interventional

Study Design: randomized controlled trial, double blind, placebo control, parallel assignment, treatment purpose

Primary Sponsor: Ishikawa Masashi

Condition: Mild Cognitive Impairment (MCI) associated with aging Mild Cognitive Impairment Cognitive decline Age-related cognitive impairment Mild Cognitive Impairment [MeSH ID: D000544]

Intervention: Intranasal administration of iPS cell-derived exosomes. Participants are randomized into three grou...